GluA4-Targeted AAV Vectors Deliver Genes Selectively to Interneurons while Relying on the AAV Receptor for Entry

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

GluA4-Targeted AAV Vectors Deliver Genes Selectively to Interneurons while Relying on the AAV Receptor for Entry. / Hartmann, Jessica; Thalheimer, Frederic B.; Höpfner, F.; Kerzel, Thomas; Khodosevich, Konstantin; García-González, D.; Monyer, Hannah; Diester, Ilka; Büning, Hildegard; Carette, J. E.; Fries, Pascal; Buchholz, Christian J.

In: Molecular Therapy - Methods & Clinical Development, Vol. 14, 2019, p. 252-260.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Hartmann, J, Thalheimer, FB, Höpfner, F, Kerzel, T, Khodosevich, K, García-González, D, Monyer, H, Diester, I, Büning, H, Carette, JE, Fries, P & Buchholz, CJ 2019, 'GluA4-Targeted AAV Vectors Deliver Genes Selectively to Interneurons while Relying on the AAV Receptor for Entry', Molecular Therapy - Methods & Clinical Development, vol. 14, pp. 252-260. https://doi.org/10.1016/j.omtm.2019.07.004

APA

Hartmann, J., Thalheimer, F. B., Höpfner, F., Kerzel, T., Khodosevich, K., García-González, D., ... Buchholz, C. J. (2019). GluA4-Targeted AAV Vectors Deliver Genes Selectively to Interneurons while Relying on the AAV Receptor for Entry. Molecular Therapy - Methods & Clinical Development, 14, 252-260. https://doi.org/10.1016/j.omtm.2019.07.004

Vancouver

Hartmann J, Thalheimer FB, Höpfner F, Kerzel T, Khodosevich K, García-González D et al. GluA4-Targeted AAV Vectors Deliver Genes Selectively to Interneurons while Relying on the AAV Receptor for Entry. Molecular Therapy - Methods & Clinical Development. 2019;14:252-260. https://doi.org/10.1016/j.omtm.2019.07.004

Author

Hartmann, Jessica ; Thalheimer, Frederic B. ; Höpfner, F. ; Kerzel, Thomas ; Khodosevich, Konstantin ; García-González, D. ; Monyer, Hannah ; Diester, Ilka ; Büning, Hildegard ; Carette, J. E. ; Fries, Pascal ; Buchholz, Christian J. / GluA4-Targeted AAV Vectors Deliver Genes Selectively to Interneurons while Relying on the AAV Receptor for Entry. In: Molecular Therapy - Methods & Clinical Development. 2019 ; Vol. 14. pp. 252-260.

Bibtex

@article{b82f95341c2c4eefa1ff64e3374e3008,
title = "GluA4-Targeted AAV Vectors Deliver Genes Selectively to Interneurons while Relying on the AAV Receptor for Entry",
abstract = "Selective gene delivery into subtypes of interneurons remains an important challenge in vector development. Adeno-associated virus (AAV) vector particles are especially promising for intracerebral injections. For cell entry, AAV2 particles are supposed to attach to heparan-sulfate proteoglycans (HSPGs) followed by endocytosis via the AAV receptor (AAVR). Here, we assessed engineered AAV particles deficient in HSPG attachment but competent in recognizing the glutamate receptor 4 (GluA4, also known as GluRD or GRIA4) through a displayed GluA4-specific DARPin (designed ankyrin repeat protein). When injected into the mouse brain, histological evaluation revealed that in various regions, more than 90{\%} of the transduced cells were interneurons, mainly of the parvalbumin-positive subtype. Although part of the selectivity was mediated by the DARPin, the chosen spleen focus-forming virus (SFFV) promoter had contributed as well. Further analysis revealed that the DARPin mediated selective attachment to GluA4-positive cells, whereas gene delivery required expression of AAVR. Our data suggest that cell selectivity of AAV particles can be modified rationally and efficiently through DARPins, but expression of the AAV entry receptor remains essential.",
keywords = "AAV, AAVR, GluA4, interneuron, parvalbumin, PV, targeting",
author = "Jessica Hartmann and Thalheimer, {Frederic B.} and F. H{\"o}pfner and Thomas Kerzel and Konstantin Khodosevich and D. Garc{\'i}a-Gonz{\'a}lez and Hannah Monyer and Ilka Diester and Hildegard B{\"u}ning and Carette, {J. E.} and Pascal Fries and Buchholz, {Christian J.}",
year = "2019",
doi = "10.1016/j.omtm.2019.07.004",
language = "English",
volume = "14",
pages = "252--260",
journal = "Molecular Therapy - Methods & Clinical Development",
issn = "2329-0501",
publisher = "nature publishing group",

}

RIS

TY - JOUR

T1 - GluA4-Targeted AAV Vectors Deliver Genes Selectively to Interneurons while Relying on the AAV Receptor for Entry

AU - Hartmann, Jessica

AU - Thalheimer, Frederic B.

AU - Höpfner, F.

AU - Kerzel, Thomas

AU - Khodosevich, Konstantin

AU - García-González, D.

AU - Monyer, Hannah

AU - Diester, Ilka

AU - Büning, Hildegard

AU - Carette, J. E.

AU - Fries, Pascal

AU - Buchholz, Christian J.

PY - 2019

Y1 - 2019

N2 - Selective gene delivery into subtypes of interneurons remains an important challenge in vector development. Adeno-associated virus (AAV) vector particles are especially promising for intracerebral injections. For cell entry, AAV2 particles are supposed to attach to heparan-sulfate proteoglycans (HSPGs) followed by endocytosis via the AAV receptor (AAVR). Here, we assessed engineered AAV particles deficient in HSPG attachment but competent in recognizing the glutamate receptor 4 (GluA4, also known as GluRD or GRIA4) through a displayed GluA4-specific DARPin (designed ankyrin repeat protein). When injected into the mouse brain, histological evaluation revealed that in various regions, more than 90% of the transduced cells were interneurons, mainly of the parvalbumin-positive subtype. Although part of the selectivity was mediated by the DARPin, the chosen spleen focus-forming virus (SFFV) promoter had contributed as well. Further analysis revealed that the DARPin mediated selective attachment to GluA4-positive cells, whereas gene delivery required expression of AAVR. Our data suggest that cell selectivity of AAV particles can be modified rationally and efficiently through DARPins, but expression of the AAV entry receptor remains essential.

AB - Selective gene delivery into subtypes of interneurons remains an important challenge in vector development. Adeno-associated virus (AAV) vector particles are especially promising for intracerebral injections. For cell entry, AAV2 particles are supposed to attach to heparan-sulfate proteoglycans (HSPGs) followed by endocytosis via the AAV receptor (AAVR). Here, we assessed engineered AAV particles deficient in HSPG attachment but competent in recognizing the glutamate receptor 4 (GluA4, also known as GluRD or GRIA4) through a displayed GluA4-specific DARPin (designed ankyrin repeat protein). When injected into the mouse brain, histological evaluation revealed that in various regions, more than 90% of the transduced cells were interneurons, mainly of the parvalbumin-positive subtype. Although part of the selectivity was mediated by the DARPin, the chosen spleen focus-forming virus (SFFV) promoter had contributed as well. Further analysis revealed that the DARPin mediated selective attachment to GluA4-positive cells, whereas gene delivery required expression of AAVR. Our data suggest that cell selectivity of AAV particles can be modified rationally and efficiently through DARPins, but expression of the AAV entry receptor remains essential.

KW - AAV

KW - AAVR

KW - GluA4

KW - interneuron

KW - parvalbumin

KW - PV

KW - targeting

U2 - 10.1016/j.omtm.2019.07.004

DO - 10.1016/j.omtm.2019.07.004

M3 - Journal article

VL - 14

SP - 252

EP - 260

JO - Molecular Therapy - Methods & Clinical Development

JF - Molecular Therapy - Methods & Clinical Development

SN - 2329-0501

ER -

ID: 226872807